Related Experiment Video
Updated: May 8, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Second primary malignancies following thyroid cancer: a population-based study in Taiwan
Chang-Hsien Lu1, Kuan-Der Lee, Ping-Tsung Chen
1Department of Hematology and Oncology, Chang-Gung Memorial Hospital, No. 6, Chia-Pu Road, Putz City, Chia-Yi, Taiwan.
European Journal of Endocrinology
|August 14, 2013
Summary
Thyroid cancer survivors have a 33% increased risk of developing second primary malignancies (SPMs). This increased risk, particularly for certain cancers, negatively impacts survival rates in Asian populations.
Area of Science:
- Epidemiology
- Oncology
- Public Health
Background:
- Most studies on second primary malignancies (SPMs) after thyroid cancer originate from Western countries, potentially overlooking geographical and ethnic variations.
- Epidemiological data on SPMs in Asian thyroid cancer survivors are limited, necessitating region-specific investigations.
Purpose of the Study:
- To determine the incidence and risk of SPMs in a large cohort of thyroid cancer survivors in Taiwan.
- To identify specific cancer sites with elevated SPM risk in this population.
- To compare SPM patterns between Asian and Western populations.
Main Methods:
- A population-based study utilized the Taiwan Cancer Registry (1979-2006).
- Standardized incidence ratios (SIRs) and cumulative incidence of SPMs were calculated for 19,068 thyroid cancer patients.
- Follow-up data covered 134,678 person-years.
Main Results:
- A total of 644 SPMs (3.38%) were diagnosed. Thyroid cancer survivors had a 33% higher risk of SPMs (SIR=1.33).
- Elevated risks were observed for major salivary glands, nasopharyngeal, lung, thymus, breast, bladder, brain cancers, leukemia, and lymphoma.
- The highest SPM risk occurred within 5 years of thyroid cancer diagnosis and in younger patients (<50 years).
Conclusions:
- Thyroid cancer significantly increases the risk of SPMs, adversely affecting patient survival.
- Distinctive SPM sites in the Asian population suggest potential genetic or environmental factors differing from Western populations.
- These findings highlight the need for tailored surveillance strategies for thyroid cancer survivors, considering ethnic and geographic variations.
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
